Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × Other solid neoplasm × Clear all

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT05645523 2026-02-25

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07220447 2026-02-12

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06824155 2026-02-11

RAD202

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Gene Mutation

NCT04733027 2026-01-22

Clever Peptide

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Metastatic Solid Tumor Cancer

NCT07349160 2026-01-16

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05245682 2026-01-08

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Phase EARLY_PHASE1 Active not recruiting

10 enrolled 8 charts

Head & NeckOther solid neoplasm

Head and Neck Carcinoma of Unknown Primary

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor Malignancies

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06380309 2025-12-23

A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor of Digestive System

NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07266311 2025-12-05

CAR-T for Claudin18.2 Positive Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Claudin18.2 Positive Advanced Solid Tumors

NCT05021120 2025-12-04

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumours

NCT07009184 2025-11-18

CleavHER

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Positive Solid Tumor

NCT07182435 2025-09-19

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor Malignancies

NCT05245058 2025-08-17

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2-positive Advanced Solid Tumors

NCT06822998 2025-08-17

HF50

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06610227 2025-07-16

A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumors

NCT06976931 2025-05-16

Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Recurrence, Retinoblastoma

NCT06951425 2025-05-13

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06400485 2025-05-02

AMT-676 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06497010 2025-05-01

An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05916248 2025-04-01

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04213794 2025-02-20

TOASTIT

Phase EARLY_PHASE1 Terminated

GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT06094426 2025-02-17

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06820424 2025-02-11

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

CDH17-positive Advanced Solid Tumors

NCT06713148 2025-02-06

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT06718946 2025-02-06

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT05908773 2025-01-28

A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT06026605 2025-01-16

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Unresectable or Metastatic Advanced Solid Tumors

NCT06695689 2024-11-19

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT02748798 2024-10-15

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Phase EARLY_PHASE1 Terminated

Other solid neoplasmThoracic

Asbestosis, Asthma, Bronchiectasis, Cystic Fibrosis, Emphysema, Rhinitis, Allergic, Seasonal, Hypertension, Pulmonary, Lung Neoplasms, Mesothelioma, Pulmonary Embolism, Pulmonary Fibrosis, Lung Diseases, Interstitial, Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06613152 2024-09-25

HS-IT201 Injection in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05515692 2024-07-23

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Phase EARLY_PHASE1 Withdrawn

OtherOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT05579275 2024-05-14

Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Malignant Solid Tumors

NCT05087745 2024-04-17

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06327997 2024-03-25

An Exploratory Study by Fast CAR T Cells

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04552418 2024-02-28

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT06248697 2024-02-08

Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06249256 2024-02-08

An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT03863145 2024-02-07

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT05490264 2023-12-07

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05971576 2023-08-02

A Clinical Study on TILs for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05971589 2023-08-02

A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor